Quellen
1Lauritzen T, Pramming S, Decker T, Binder C: Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 1983; 24: 326-329.
2Graff MR, Rubin RR, Walker EA: How specialists treat their own diabetes: Findings from a study of the AADE and ADA membership. The Diabetes Educator 2000; 26: 460-467.
3Bode BW, Gross T, Steed D, Davidson P: A recent assessment of continuation rates for continuous subcutaneous insulin infusion (CSII). Diabetes 1998; 47 (Beilage 1): 392.
4Wredling R, Hannerz L, Johansson U-B: Variability of blood glucose levels in patients treated with continuous subcutaneous insulin infusion: a pilot study. Practical Diabetes 1997; 14: 5-8.
5Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996; 19: 324-327.
6Chantelau E, Schiff ers T, Schutze J, Hanson B: Eff ect of patient selected intensive insulin therapy on quality of life. Patient education and counseling 1997; 30: 167-173.
7Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV: A new way to lower risk of severe hypoglycemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999; 22: 1779-1784.
8Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T: Eff ect of improved metabolic control on loss of kidney function in Type 1 (insulin dependent) diabetic patient: an update of the steno studies. Diabetologia 1991; 24: 164-170.
9Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. NEJM 1993; 977-986.
10Pietri A, Ehle AL, Raskin P: Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 1980; 29: 668-671.
11Schmitz O, Sorensen S, Alberti K, Orskov H, Hansen NE: Metabolic control in newly transplanted insulin-dependent diabetes: improvement by insulin pump treatment (CSII). Journal of Diabetic Complication 1987; 1: 81-86.
12Barbosa J, Menth L, Eaton J, Sutherland D, Frier IF, Najarian J: Long-term ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients. Diabetes Care 1981; 4:269-274.
13T. Gross, D. Kayne, A. King, C. Rother, S. Juth: The bolus estimator aids patients in accurately adjusting pre-meal insulin boluses. ADA 2003 Abstract- Bolus Estimator #136.
14P. Davidson, H. Hebblewhite: An Insulin pump prescribing nomogram based on 173 patients treated to target.
15P. Davidson, H Hebblewhite, Bruce W Bode, Pat L Richardson, R Dennis Seed, N Spencer Welch, Evie Poulos and Partia Ybanez: An empirical basis for modifying the “1500 Rule”.
16EA Doyle (Boland) Weinzimer SA, Ahern JAH, Steff en AT, Tamborlane WV. A Randomized, Prospective Trial Comparing the Effi cacy of CSII with MDI using Insulin Glargine. Diabetes